A national survey of Canadian practice patterns of warfarin after anterior wall myocardial infarction in the current era of dual antiplatelet therapy.
Jon-David R
JD
Schwalm
Mayraj
M
Ahmad
John W
JW
Eikelboom
Madhu K
MK
Natarajan
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D002170:Canada / Q000453:epidemiology; D004359:Drug Therapy, Combination; D006331:Heart Diseases / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D017063:Outcome Assessment, Health Care; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011159:Population Surveillance / Q000379:methods*; D010818:Practice Patterns, Physicians'; D013927:Thrombosis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin